In Vivo Study of THC-induced Immune-genome Changes at Single Cell Solution in HIV-infected Humans
Completed · Phase 1
Conditions studied: HIV Infections, Healthy
In brief
In this study, the investigators hypothesize that THC alters the immunogenome in a cell type-specific fashion and alters cytokine production via epigenetic regulatory mechanisms and that these alterations differ between HIV-infected and HIV-uninfected host genomes.
Key facts
- Study ID
- NCT04920539
- Run by
- Yale University
- People needed
- 56
- Starts
- 2022-02-08
- Expected to finish
- 2025-12-30
- Last updated by the study team
- 2026-02-27
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: accepted.
Where it is running
- VA Connecticut Healthcare System — West Haven, Connecticut, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.